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Abstract 
Big Data can unify all patient related data to get a 360-degree view of the patient to analyze 
and predict outcomes. This investigation examines the concepts and characteristics of Big 
Data, concepts about Translational Bio Informatics and some public available big data 
repositories and major issues of big data. This issue covers the area of medical and 
healthcare applications and its opportunities.  
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Big Data Concepts 
Big data is a blanket term for the non-
traditional strategies and technologies 
needed to gather, organize, process, and 
gather insights from large datasets. 
Characteristics of big data can be 
described us 6 V’s, that are following 
Volume, Velocity, Variety, Value, 
Variability and Veracity [1, 2, 3] 
 
Volume 
It refers to as terabytes, petabytes, and 
zettabytes of data. This focus on near 
instant feedback has driven many big data 
practitioners away from a batch-oriented 
approach and closer to a real-time 
streaming system. Data is constantly being 
added, massaged, processed, and analyzed 
in order to keep up with the influx of new 
information and to surface valuable 
information early when it is most relevant.  
 
Variety  
While more traditional data processing 
systems might expect data to enter the 
pipeline already labeled, formatted, and 
organized, big data systems usually accept 
and store data closer to its raw state.  
 
Big data life cycle looks like 
So how is data really handled when 
managing with a big data framework? 
While ideas to exertion differ, there are 
some populace in the scenario and 
software that we can discuss for the most 
part. While the means exhibited 
underneath won't not be valid in all cases, 
they are broadly utilized. 
The general tier of task embroiled with big 
data processing is: 
 Ingesting data into the system 
 Persisting the data in storage 
 Computing and Analyzing data 
 Visualizing the results 
In Big data technology, we will take a 
moment to talk about clustered computing, 
an important strategy employed by most 
big data solutions. 
 
CLUSTERED COMPUTING 
Resource Pooling: Combining the 
available storage space to hold data is a 
clear benefit, but CPU and memory 
pooling is also extremely important.  
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High Availability: Clusters can provide 
varying levels of fault tolerance and 
availability guarantees to prevent hardware 
or software failures from affecting access 
to data and processing.  
 
Easy Scalability: Clusters make it easy to 
scale horizontally by adding additional 
machines to the group.  
There is often noisy data or false 
information in big data. The focus of Big 
Data is on correlations, not causality [4].  
 
CATEGORIES OF MEDICAL BIG 
DATA 
Data in healthcare can be categorized as 
follows.  
 
Genomic Data 
Such data are gathered by a bioinformatics 
system or genomic data processing 
software. Data sequencing analysis 
techniques and variation analysis are 
common processes performed on genomic 
data. The aim of genomic data analysis is 
to determine the functions of specific 
genes. It refers to genotyping, gene 
expression and DNA sequence [6, 7].  
 
Clinical Data 
A term defined in the context of a clinical t
rial for data pertaining to the health status 
of a patient or subject [8]. About 80% of 
this type data are unstructured documents, 
images and clinical or transcribed notes [9] 
Structured data (e.g., laboratory data, 
structured EMR/HER) 
 
Behaviour Data and Patient Sentiment 
Data 
Behavioural data refers to information 
produced as a result of actions, typically 
commercial behaviour using a range of 
devices connected to the Internet, such as a 
PC, tablet, or Smartphone. Behavioural 
data tracks the sites visited, the apps 
downloaded, or the games played. • Web 
and social media data Search engines, 
Internet consumer use and networking 
sites (Facebook, Twitter, Linkedin, blog, 
health plan websites and smartphone, etc.) 
[10] 
 
Clinical reference and health 
publication data 
It refers to reference data for clinical, 
claim, and business data to enable 
interoperability, drive compliance, and 
improve operational efficiencies.  
Text-based publications (journals articles, 
clinical research and medical reference 
material) and clinical text-based reference 
practice guidelines and health product 
(e.g., drug information) data [7, 12].  
 
Administrative, Business and External 
Data 
 Insurance claims and related financial 
data, billing and scheduling [10] 
 Biometric data: Fingerprints, 
handwriting and iris scans, etc 
 Other Important Data 
 Device data, adverse events and patient 
feedback, etc. [9] 
 The content from portal or Personal 
Health Records (PHR) messaging 
(such as e-mails) between the patient 
and the provider team; the data 
generated in the PHR Ingesting data 
into the system 
 Persisting the data in storage 
 Computing and Analyzing data 
 Visualizing the results 
 
Big data in Health Informatics:  
However, the scope of this study will be 
research that uses data mining in order to 
answer questions throughout the various 
levels of health[13].  
 
The scope of data used by the subfield 
TBI, on the other hand, exploits data from 
each of these levels, from the molecular 
level to entire populations [14].  
 
BIG DATA AND DRUG DISCOVERY 
In today drug discovery environment, Big 
Data plays a vital role due to its 5 V 
concepts. These databases provide 
information about the drugs, their adverse 
  
 
20 Page 18-27 © MAT Journals 2019. All Rights Reserved 
 
Journal of Electronics and Communication Systems  
Volume 4 Issue 1 
reactions, 1chemical formula, information 
about metabolic pathways, drug targets, 
disease for which a particular drug is used 
etc. None of the existing 
pharmacogenomic databases carry the 
complete integrated information and hence 
there is a need to develop a database which 
integrates data from all the widely used 
databases [38]. 
Integrating big data analytics and 
validating drugs in silico has the potential 
to improve the cost-effectiveness of the 
drug development pipeline. Big data–
driven strategies are being increasingly 
used to address these challenges. 
Computational prediction of drug toxicity 
and pharmacodynamic/pharmacokinetic 
properties, based on integration of multiple 
data types, helps prioritize compounds for 
in vivo and human testing, potentially 
reducing costs[39]. 
 
DRUG DISCOVERY RELATED BIG 
DATA SOURCES 
Data sets and resources available on 
Related to drug discovery are scattered in 
various databases and online resources and 
most of these databases are interlinked 
based on the information they carry. Some 
of these databases include PharmGKB 
[40], DrugBank [41], CTD [42], Reactome 
[43], KEGG [46], STITCH [47], PACdb 
[48], dbGaP [49] IGVdb, PGP [50]. Brief 
explanation of the databases are given in 
the following section and also tabulated in 
table 2. 
 
PharmGKB 
PharmGKB is a pharmocogenomics 
database that carries all the clinical 
information along with the dosage 
guidelines, gene-drug associations and 
genotype phenotype relationships. It also 
has information about Variant 
Annotations, Clinical Annotations and 
Very Important Pharmacogene (VIP) 
summaries, drug-centered pathways. 
 
Drug Bank 
Drug Bank database is the open resource 
for drug, drug targets, and chemo 
informatics. It contains 11,067 drug entries 
including 2,525 approved small molecule 
drugs, 960 approved biotech 
(protein/peptide) drugs, 112 nutraceuticals 
and over 5,125 experimental drugs. 
Additionally, 4,924 non-redundant protein 
(i.e. drug 
target/enzyme/transporter/carrier) 
sequences are linked to these drug entries. 
Each Drug Card entry contains more than 
200 data fields with half of the information 
being devoted to drug/chemical data and 
the other half devoted to drug target or 
protein data. 
 
CTD 
The whole database is categorized in to 11 
types: 
Chemicals, genes, chemical-gene/protein 
interactions, diseases, gene-disease 
associations, chemical-disease 
associations, references, organisms, gene 
ontology, pathways and exposures.  
 
Reactome 
It has cross-referenced to several other 
databases such as Ensembl [44] and 
UniProt. The pathways within the database 
especially those pertaining to those in 
humans may be used for research and 
analysis, pathways modelling, systems 
biology as well as pharmacogenomics 
applications to analyze effects of drug 
pathway alterations on drug response and 
phenotypes [45]. 
 
KEGG  
It is an integrated resource of systems 
information (KEGG Pathways, KEGG 
Brite, KEGG Module, KEGG Disease, 
KEGG Drug and KEGG Environ), 
genomics information (KEGG Orthology, 
KEGG Genes, KEGG Genome, KEGG 
DGenes and KEGG SSDB) and chemical 
information (KEGG Compounds, KEGG 
Glycans, KEGG Reaction, KEGG RPair, 
KEGG RClass and KEGG Enzyme). 
 
STITCH 
STITCH (Search Tool for Interacting 
Chemicals) is a database of known and 
predicted interactions between chemicals 
and proteins. The interactions include 
direct (physical) and indirect (functional) 
associations; they stem from 
computational prediction, from knowledge 
transfer between organisms, and from 
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interactions aggregated from other 
(primary) databases. It also includes data 
on interactions between 210,914 small 
molecules and 9’643’763 proteins from 
2'031 organisms  
 
Other databases 
dpGaP (Database of Genotypes and 
Phenotypes) is database of genotype-
phenotype association studies, genome-
wide association studies, as well as 
associations between genotype and non-
clinical traits. It was developed to archive 
and distribute the data and results from 
studies that have investigated the 
interaction of genotype and phenotype in 
Humans. 
 
PACdb (Pharamacogenomics and Cell 
database) contains information on the 
relationships between SNPs, gene 
expression and cellular sensitivity to drugs 
analyzed in cell-based models. It is a 
Pharmacogenetics-Cell line database for 
use as a central repository of 
pharmacology-related phenotypes that 
integrates genotypic, gene expression, and 
pharmacological data obtained via 
lymphoblastoid cell lines. 90 YRI LCLs as 
well as ExiqonmiRNA baseline data from 
60 unrelated CEU and 60 unrelated YRI 
have been deposited in the PACdb 
database. 
 
IGVd (Indian Genome Variation database) 
contains information about SNP, CNVs in 
over 
1000 genes of biomedical important 
metabolic and genetic networks and also 
genes of pharmacogenetic relevance [51].  
 
There are many other biological databases 
such as Uniprot, GO, GenBank, PDB have 
cross-reference to above databases whose 
information may serve as essential source 
for drug and it related studies.
 
Table 1: Levels of Data 
Sections 
 Data level(s) 
Used 
 Subsections  
Question level(s) 
answered  
Questions to be answered 
Using Micro 
Level Data –
Molecules 
Molecular 
Using Gene Expression 
Data to Make Clinical 
Predictions 
Clinical 
1. What sub-type of cancer does 
a patient have? [18]    2. Will a 
patient have a relapse of cancer? 
[19] 
Using Tissue 
Level Data 
Tissue 
Creating a Connectivity 
Map of the Brain Using 
Brain Images 
Human-Scale 
Biology 
Can a full connectivity map of 
the brain be made [20,21]? 
Patient 
Using MRI Data for 
Clinical Prediction 
Clinical 
Do particular areas of the brain 
correlate to clinical events? [22] 
Using Patient 
Level Data 
Patient 
Prediction of ICU 
Readmission and 
Mortality Rate 
Clinical 
1. Should a patient be released 
from the ICU, or would they 
benefit from a longer stay?[23-
25]               2. What is the 5 
year expectancy of a patient 
over the age of 50? [26] 
Real-Time Predictions 
Using Data Streams 
1. What ailment does a patient 
have (real-time prediction) 
[27,28]  2. Is an infant 
experiencing a cardiorespiratory 
spell (real-time)? [29] 
Using Population 
Level Data – 
Social Media 
Population 
Using Message Board 
Data to Help Patients 
Obtain Medical 
Information 
Clinical 
Can message post data be used 
for dispersing clinically reliable 
information? [30,31] 
Tracking Epidemics 
Using Search Query Data 
Epidemic-Scale 
Can search query data be used to 
accurately track epidemics 
throughout a population? 
[32,33] 
Tracking Epidemics 
Using Twitter Post Data 
Epidemic-Scale 
Can Twitter post data be used to 
accurately 
track epidemics throughout a 
population?[34,35] 
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Table 2: Some Bio Informatics related Big Data Resources Which is publicly available 
Category  Name  Description  URL 
Literature mining PolySearch 2.0 Web-based text mining tool http://polysearch.cs.ualberta.ca 
Machine learning Weka 
Extensive library of machine learning 
algorithms with a user-friendly 
interface  
http://www.cs.waikato.ac.nz/ml/weka/ 
Cheminformatics 
Drug Bank 
Database 
Database of drug chemical, structural, 
pharmacological, and target 
information 
http://www.drugbank.ca 
PubChem 
Comprehensive database of structural, 
pharmacological, and biochemical 
activity data 
https://pubchem.ncbi.nlm.nih.gov/ 
Protein Data 
Bank 
Repository of protein structural data http://www.wwpdb.org 
admetSAR 
Web tool predicting pharmacological 
and toxicology parameters based on 
chemical structures 
http://lmmd.ecust.edu.cn:8000/ 
The Drug Gene 
Interaction 
Database 
(DGIdb) 
Database of known drug-gene 
connections for selected genes 
http://dgidb.genome.wustl.edu/ 
SIDER Database of drug adverse effects http://sideeffects.embl.de/ 
Library of 
Integrated 
Cellular 
Signatures 
(LINCS) 
Database of functional cellular 
responses to genetic and 
pharmacological perturbations 
measured in multiple types of 
biomolecules (eg,transcriptome and 
kinome) 
http://lincsportal.ccs.miami.edu/dataset
s/ 
ChemBank 
Database/knowledge base of high- 
throughput compound screens and 
other small molecule–related 
information 
http://chembank.broadinstitute.org/ 
Molecular 
pathway 
knowledgebase/ 
analysis tool 
DAVID 
Searchable/downloadable database of 
molecular pathway knowledge base 
https://david.ncifcrf.gov/ 
NDEx Biological network knowledge base http://www.home.ndexbio.org/ 
Molecular 
Signatures 
Database 
(MSigDb) 
Repository of molecular signatures 
from curated databases, publications, 
and research studies 
http://www.broadinstitute.org/msigdb 
Omics data 
repositories 
Gene Expression 
Omnibus 
Repository of raw and processed omics 
data 
http://www.ncbi.nlm.nih.gov/geo/ 
Sequence Read 
Archive 
Repository of sequencing data http://www.ncbi.nlm.nih.gov/sra 
Array Express 
Repository of raw and processed omics 
data 
https://www.ebi.ac.uk/arrayexpress/ 
The Cancer 
Genome Atlas 
Repository of genomic, proteomic,  
histological, and clinical data for a 
wide variety of cancers 
https://tcga-data.nci.nih.gov/tcga/ 
tcgaHome2.jsp 
 
CONCLUSION  
Big data is a broad, rapidly evolving topic. 
This survey discussed a number of recent 
studies being done within the most popular 
sub branches of Health Informatics, using 
Big Data from all accessible levels of 
human existence to answer questions 
throughout all levels. Analyzing Big Data 
of this scope has only been possible 
extremely recently, due to the increasing 
capability of both computational resources 
and the algorithms which take advantage 
of these resources. Research on using these 
tools and techniques for Health 
Informatics is critical, because this domain 
requires a great deal of testing and 
confirmation before new techniques can be 
applied for making real world decisions 
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across all levels. The fact that 
computational power has reached the 
ability to handle Big Data through efficient 
algorithms.  The use of Big Data provides 
advantages to Health Informatics by 
allowing for more tests cases or more 
features for research, leading to both 
quicker validations of studies.  
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